CVE-2006-1384

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in apwc_win_main.jsp in the web console in IBM Tivoli Business Systems Manager (TBSM) before 3.1.0.1 allows remote attackers to inject arbitrary web script or HTML via the skin parameter.

4.3

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 0.79% Top 30%

Vendor Advisory ibm.com Vendor Advisory secunia.com

Affected: n/a n/a

References

Link	Tags
http://www-1.ibm.com/support/docview.wss?uid=swg1OA14904	exploit patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/25412	vdb entry
http://www.osvdb.org/24069	vdb entry
http://secunia.com/advisories/19332	exploit third party advisory patch vendor advisory
http://www.vupen.com/english/advisories/2006/1073	vdb entry
http://securitytracker.com/id?1015822	vdb entry
http://www.securityfocus.com/bid/17210	vdb entry

Frequently Asked Questions

What is the severity of CVE-2006-1384?: CVE-2006-1384 has been scored as a medium severity vulnerability.
How to fix CVE-2006-1384?: To fix CVE-2006-1384, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2006-1384 being actively exploited in the wild?: It is possible that CVE-2006-1384 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.